IL22 and colitis: A comprehensive metabolomic and microbiota profiling revealed an important correlation between indole-3-carbinol, glucobrassicin metabolite, Roseburia spp., a butyrate-producing bacteria, and IL22, an anti-inflammatory cytokine, for gut protection against colitis [161].